SERUM COPPER AND THE RISK OF ACUTE MYOCARDIAL-INFARCTION - A PROSPECTIVE POPULATION STUDY IN MEN IN EASTERN FINLAND

被引:152
作者
SALONEN, JT
SALONEN, R
KORPELA, H
SUNTIOINEN, S
TUOMILEHTO, J
机构
[1] UNIV KUOPIO,PUBL HLTH RES INST,SF-70211 KUOPIO 21,FINLAND
[2] UNIV KUOPIO,DEPT CHEM,SF-70211 KUOPIO 21,FINLAND
[3] NATL PUBL HLTH INST,DEPT EPIDEMIOL,SF-00280 HELSINKI 28,FINLAND
关键词
COPPER; CORONARY DISEASE; LONGITUDINAL STUDIES; TRACE ELEMENTS;
D O I
10.1093/oxfordjournals.aje.a116080
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The authors investigated the association of serum copper concentration with the risk of acute myocardial infarction in 1,666 randomly selected men aged 42, 48, 54, or 60 years who had no symptomatic ischemic heart disease at entry. Baseline examinations in the Kuopio Ischaemic Heart Disease Risk Factor Study in Eastern Finland were done during 1984 to 1988. In Cox multivariate survival models adjusting for age, examination year, ischemic electrocardiogram in exercise, maximal oxygen uptake, diabetes, family history of ischemic heart disease, cigarette-years, mean systolic blood pressure, serum high density lipoprotein (HDL) cholesterol subfraction HDL2 and low density lipoprotein (LDL) cholesterol concentrations and blood leukocyte count, serum copper concentration in the two highest tertiles (1.02-1.16 mg/liter and 1.17 mg/liter or more) associated with 3.5-fold (95% confidence interval (Cl) 1.3-9.4, p < 0.05) and 4.0-fold (95 percent Cl 1.5-10.8, p < 0.01) risk of acute myocardial infarction. These data indicate that high copper status, reflected by elevated serum copper concentration, is an independent risk factor for ischemic heart disease.
引用
收藏
页码:268 / 276
页数:9
相关论文
共 37 条
  • [1] [Anonymous], 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138
  • [2] [Anonymous], 2015, FREE RADICAL BIO MED
  • [3] HAIR ZINC AND COPPER CONCENTRATION IN SURVIVORS OF MYOCARDIAL-INFARCTION
    BIALKOWSKA, M
    HOSER, A
    SZOSTAK, WB
    DYBCZYNSKI, R
    STERLINSKI, S
    NOWICKA, G
    MAJCHRZAK, J
    KACZOROWSKI, J
    DANKO, B
    [J]. ANNALS OF NUTRITION AND METABOLISM, 1987, 31 (05) : 327 - 332
  • [4] CARLSON K, 1973, J CLIN PATHOL S5, V26, P32
  • [5] COX DR, 1972, J R STAT SOC B, V34, P187
  • [6] DIXON WJ, 1985, BMDP STATISTICAL SOF
  • [7] CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN
    ESTERBAUER, H
    STRIEGL, G
    PUHL, H
    ROTHENEDER, M
    [J]. FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01): : 67 - 75
  • [8] GUTTERIDGE JMC, 1985, MED BIOL, V63, P41
  • [9] CERULOPLASMIN - PHYSIOLOGICAL AND PATHOLOGICAL PERSPECTIVES
    GUTTERIDGE, JMC
    STOCKS, J
    [J]. CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1981, 14 (04): : 257 - 329
  • [10] HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737